cilengitide has been researched along with Multiple Myeloma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cafforio, P; Felici, C; Resta, L; Rossi, R; Silvestris, F; Stucci, S; Tucci, M | 1 |
1 other study(ies) available for cilengitide and Multiple Myeloma
| Article | Year |
|---|---|
Cilengitide restrains the osteoclast-like bone resorbing activity of myeloma plasma cells.
Topics: Apoptosis; Bone Resorption; Cell Adhesion; Cell Proliferation; Female; Humans; Integrin alphaVbeta3; Male; Multiple Myeloma; Neoplasm Proteins; Osteoclasts; Plasma Cells; Receptors, Vitronectin; Snake Venoms; Tumor Cells, Cultured | 2016 |